Image description

Special Report: RxImpact 2016

In this special report, Drug Store News takes an in-depth look at community pharmacy and its growing role in helping to lower healthcare costs and expand patient access in the United States.

Image description

Legislative progress: Q&A with NACDS’s Steve Anderson

Drug Store News caught up with NACDS president and CEO Steve Anderson for a recap of 2016 and a look ahead at what to expect from a Trump administration.

DSN: What is the RxImpact scorecard for 2016? How did the industry do on the key pharmacy and patient access issues?

Image description

Trump’s plan to shift the cost burden

The bottom line behind President-elect Donald Trump’s proposals: The cost burden of the $3 trillion industry will shift away from the federal government and toward private enterprise, state government and consumers.

Image description

FDA Office of New Drugs director Jenkins to retire

The Food and Drug Administration’s director of the Center for Drug Evaluation and Research, Dr. Janet Woodcock, said that the agency would conduct a national search to fill the vacancy left by retiring Office of New Drugs director Dr. John Jenkins, and that in the interim, she would be acting director of the OND.